The Valley Desk

NCT05126433 · Interventional trial

Lurbinectedin Monotherapy in Participants With Advanced or Metastatic Solid Tumors

Overall registry status Terminated

Phase 2

Conditions Advanced Solid Tumor, Homologous Recombination Deficient-Positive Malignancies Agnostic, Metastatic Solid Tumor, Poorly Differentiated Neuroendocrine Carcinomas, Urothelial Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov